BEAM
Beam Therapeutics Inc Earnings
$27.71
Earnings Summary
Revenue | $9.7Mn |
Net Profits | $-112.73Mn |
Net Profit Margins | -1162.38% |
Beam Therapeutics Inc’s revenue fell -32.03% since last year same period to $9.7Mn in the Q3 2025. On a quarterly growth basis, Beam Therapeutics Inc has generated 14.55% jump in its revenue since last 3-months.
Beam Therapeutics Inc’s net profit fell -16.61% since last year same period to $-112.73Mn in the Q3 2025. On a quarterly growth basis, Beam Therapeutics Inc has generated -10.2% fall in its net profits since last 3-months.
Beam Therapeutics Inc’s net profit margin fell -71.58% since last year same period to -1162.38% in the Q3 2025. On a quarterly growth basis, Beam Therapeutics Inc has generated 3.8% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.03 |
EPS Estimate Current Year | -1.03 |
Beam Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -1.03 - a 7.21% jump from last quarter’s estimates.
Beam Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -1.03.
Key Ratios
Earning Per Share (EPS) | -1.1 |
Beam Therapeutics Inc’s earning per share (EPS) jumped 5.98% since last year same period to -1.1 in the Q3 2025. This indicates that the Beam Therapeutics Inc has generated 5.98% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-06 | -1.17 | -1.24 | -6.04% |
2025-08-05 | -1.11 | -1 | 9.91% |
2025-11-04 | -1.03 | -1.1 | -6.8% |
